IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients.

Huan Xie Jing Zhang Ran Luo Yan Qi Yizhang Lin Changhao Han Xi Li Dongfeng Zeng

Published in: BMC immunology (2024)

Humoral immune response to SARS-CoV-2 infection was impaired in lymphoma patients partly due to anti-CD20 and ASCT treatment. COVID-19 vaccination may be more needed for these patients.

Keyphrases

end stage renal disease
immune response
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
coronavirus disease
diffuse large b cell lymphoma
dendritic cells
inflammatory response
patient reported
smoking cessation